Generated by AI
Kenvue Inc. is a consumer health company that develops, manufactures, and markets everyday health, wellness, personal care, and beauty products. Its portfolio spans three principal segments: Self Care, Skin Health and Beauty, and Essential Health. Self Care offerings include over-the-counter treatments for pain, cough, cold, allergy, digestive health, smoking cessation, and eye care, alongside vitamins, supplements, digital diagnostics, and telemedicine services. Skin Health and Beauty products cover facial and body care, hair care, sun protection, and cosmetics. Essential Health includes oral care, baby care, women’s health, wound care, and related everyday products. Recognized brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, Nicorette, Tylenol, and Zyrtec. Serving consumers through retail, digital, healthcare, and other distribution channels across major global regions, Kenvue Inc. occupies a significant role in the consumer staples and healthcare markets by connecting trusted branded products with routine health and personal care needs.
Website1 Kenvue Way
Summit, NJ, 07901
United States
The latest articles about KVUE.
We just published the list of Jim Cramer’s Top 10 Dividend Stocks for Safe, Consistent Returns and Kimberly-Clark Corporation (NASDAQ:KMB) ranked 10th on this list. From 2000 through 2009, dividends earned S&P 500 investors an annualized 1.8%, according to Hartford Funds. Even with those payments, the index posted a negative total return for the decade. […]
Kimberly-Clark’s Kenvue merger could drive 15-20% upside via synergies, EPS growth, and dividends. Click for more on KMB stock.
Summary of Nov 2's posts. Generated by AI.
Summary of Oct 16's posts. Generated by AI.
Kenvue has delivered a 26.9% gain over the past year, and after a string of mixed but steady business updates, the key issue now is how much of that share price move is backed by the cash the company can generate over time. With the stock last closing at US$19.31 and a takeover by Kimberly-Clark progressing, investors are increasingly asking whether the current valuation still lines up with the underlying cash flows of the business. The stock is up 26.9% over the past 12 months, which puts...
Summary of Jul 13's posts. Generated by AI.
Summary of Nov 2's posts. Generated by AI.
Investors talking about KVUE also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.